Key statistics
As of last trade Neogenomics Inc (NG9:STU) traded at 9.60, -29.93% below its 52-week high of 13.70, set on Feb 18, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 9.45 |
|---|---|
| High | 9.80 |
| Low | 9.45 |
| Bid | 9.60 |
| Offer | 9.75 |
| Previous close | 9.55 |
| Average volume | 666.67 |
|---|---|
| Shares outstanding | 129.39m |
| Free float | 127.75m |
| P/E (TTM) | -- |
| Market cap | 1.49bn USD |
| EPS (TTM) | -0.8877 USD |
Data delayed at least 15 minutes, as of Feb 10 2026.
More ▼
Press releases
- NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
- NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
- NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
- NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
- NeoGenomics to Present New ctDNA Research at SABCS 2025
- NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025
More ▼
